Infinium Pharmachem Limited (NSE:INFINIUM)

Infinium Pharmachem Revenue

Infinium Pharmachem had revenue of 1.06B INR in the half year ending March 31, 2026, with 42.37% growth. This brings the company's total for the last twelve months to 2.36B, up 50.29% year-over-year. In the fiscal year ending March 31, 2026, Infinium Pharmachem had annual revenue of 1.90B with 21.79% growth. That makes Infinium Pharmachem the 32,487th largest company in the world by revenue and 2,432nd in India.

• Revenue (ttm): 2.36B
• Revenue Growth: +50.29%
• P/S Ratio: 1.83
• Revenue / Employee: 16.71M
• Employees: 141
• Market Cap: 4.30B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Intermediate Chemicals 1.86B 98.3%
• Biocall 31.23M 1.7%

By Geography

Chart

• India 1.75B 92.1%
• Export 141.50M 7.5%
• Unallocated 6.07M 0.3%
• SEZ 2.72M 0.1%

Fiscal year ended Mar 31, 2026 See the full Infinium Pharmachem breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.90B	339.22M	21.79%
Mar 31, 2025	1.56B	200.50M	14.78%
Mar 31, 2024	1.36B	214.34M	18.76%
Mar 31, 2023	1.14B	151.06M	15.24%
Mar 31, 2022	991.19M	443.60M	81.01%

Data Source: S&P Global Market Intelligence Last updated: Aug 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 11, 2026

Data Sources Report a data error